FDA

Mars Petcare US recalled 315 bags of Pedigree products that were purchased through Walmart

This initial conditional approval is valid for 1 year with the potential for 4 annual renewals

Jaguar Health established an Investigation New Animal Drug file for its product Canalevia-CA1

The decision was made based on reviews from safety and quality data and information reviews

The FDA has also established an MOU with the USDA that clarifies roles and responsibilities for regulation of IGAs in animals

The Guidance for Industry will provide more clarity on veterinary feed directives

Elanco's pradofloxacin injection (Pradalex) must be prescribed by a licensed veterinarian.

DuOtic by Dechra is the first otic drug intended to treat otitis externa that does not contain an antibiotic

The Proposed Rule aims to improve content submission and format consistency

The defendant defrauded 900 pet owners out of almost $1 million

The FDA not objecting to the importation is in response to a nationwide shortage of Folltropin

GFI #286 VICH GL60 is now seeking public comments

Certain Blue Ridge Beef products may be contaminated with Salmonella and Listeria monocytogenes

The document describes the new animal drug approval process for minor uses and minor species and explains various scenarios that might arise

We have compiled a countdown of our top 15 content in 2023, here is number 11

We have compiled a countdown of our top 15 articles in 2023, here is number 15

The federal agency is is accepting public comments until February 16, 2024.

Nine manufacturers and distributors received warning letters with concerns about federal law violations

Canalevia-CA1 is the first treatment for this indication to receive the agency's support at this level

Celine Halioua, founder and CEO of Loyal, discussed the potential of LOY-001, a developmental therapy, with dvm360.

Feedback for draft GFI #273 can be submitted until January 5, 2024.

Librela and Apoquel Chewable were approved earlier this year and are now available on the market

The programs will be administered by the FDA until 2028

The agency’s Center for Veterinary Medicine has set forth its goals for the 2024 to 2028 fiscal years

The agenda is a step toward the FDA modernizing its approach to evaluating and supporting creating innovative animal and veterinary products.

The agency is accepting public comments for 60 days from the date of publication in the Federal Register, starting September 15, 2023.

Fidoquel-CA1 is indicated to treat seizures associated with the condition

Multiple lots of Darwin’s Natural Pet Products raw cat and dog food have tested positive for Salmonella